Qualigen Therapeutics Inc (QLGN) stock has fallen -71.47% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 3 out of a possible 100.
That rank is influenced by a fundamental score of 0. QLGN stock has a mean target price of $9.00. This means analysts expect the stock to climb 791.09% over the next 12 months. QLGN's rank also includes a long-term technical score of 3. The short-term technical score for QLGN is 7.
QLGN has an Overall Score of 3. Find out what this means to you and get the rest of the rankings on QLGN!
Qualigen Therapeutics Inc (QLGN) stock is lower by -0.98% while the S&P 500 has fallen -0.19% as of 11:10 AM on Thursday, Jan 13. QLGN has fallen -$0.01 from the previous closing price of $1.02 on volume of 150,121 shares. Over the past year the S&P 500 is up 23.82% while QLGN has fallen -71.47%. QLGN lost -$0.15 per share in the over the last 12 months.
Click Here to get the full Stock Report for Qualigen Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
